Sovenyr
Get early access
Signal
2026-07-26
NIH RePORTER
Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system
Part of
HIV Testing And Treatment Outcomes
Open primary source
See the whole picture